Studying the differential efficacy of postsymptom antitoxin treatment in type A versus type B botulism using a rabbit spirometry model

• मुख्य लेखकों: Amram Torgeman (लेखक), Arieh Schwartz (लेखक), Eran Diamant (लेखक), Tzadok Baruchi (लेखक), Eyal Dor (लेखक), Alon Ben David (लेखक), Avi Pass (लेखक), Ada Barnea (लेखक), Arnon Tal (लेखक), Amir Rosner (लेखक), Osnat Rosen (लेखक), Ran Zichel (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: The Company of Biologists, 2018-09-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Botulinum neurotoxin (BoNT) serotypes A, B and E are responsible for most cases of human botulism. The only approved therapy for botulism is antitoxin treatment administered to patients after symptom onset. However, a recent meta-analysis of antitoxin efficacy in human botulism cases over the past c...